Citation 88879

DUNCAN,CJG: CUENDET,M: FRONCZEK,FR: PEZZUTO,JM: MEHTA,RG: HAMANN,MT: ROSS,SA:. (2003). CHEMICAL AND BIOLOGICAL INVESTIGATION OF THE FUNGUS PULVEROBOLETUS RAVENELII.. 66(1)

Citation Details

Title	CHEMICAL AND BIOLOGICAL INVESTIGATION OF THE FUNGUS PULVEROBOLETUS RAVENELII.
Authors	DUNCAN,CJG: CUENDET,M: FRONCZEK,FR: PEZZUTO,JM: MEHTA,RG: HAMANN,MT: ROSS,SA:
Year	2003
Volume	66
Issue	1

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Pulveroboletus ravenelii (BOLETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PULVERAVEN A	None
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PULVERAVEN A	INACTIVE
7	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PULVERAVEN A	ACTIVE
8	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PULVERAVEN B	None
9	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PULVERAVEN B	INACTIVE
10	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PULVERAVEN B	INACTIVE
11	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PULVERAVEN B	ACTIVE
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDX-RAY CHRYSTALLOGRAPHIC STUDIESINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	VULPINIC ACID	None
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VULPINIC ACID	ACTIVE
14	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VULPINIC ACID	ACTIVE
15	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VULPINIC ACID	INACTIVE
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDX-RAY CHRYSTALLOGRAPHIC STUDIESINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	VULPINIC ACID POLYMORPH	None
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VULPINIC ACID POLYMORPH	ACTIVE
18	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VULPINIC ACID POLYMORPH	ACTIVE
19	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VULPINIC ACID POLYMORPH	WEAK ACTIVITY

Show SPARQL Queries (1)